Do Investigators Need Their Own Lawyers?

Investigators are often a key to success in the expanding world of collaborations between industry and universities. Yet, unlike the company and the university, the investigator is rarely represented by legal counsel. This is often the case whether the investigator serves as an independent consultant to the company or engages in company-funded research performed at the university. This situation may help to explain why university-industry relationships are plagued with controversies, includi

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Investigators are often a key to success in the expanding world of collaborations between industry and universities. Yet, unlike the company and the university, the investigator is rarely represented by legal counsel. This is often the case whether the investigator serves as an independent consultant to the company or engages in company-funded research performed at the university.

This situation may help to explain why university-industry relationships are plagued with controversies, including those affecting patents and ownership, publications, material exchanges, and increasing secretiveness. Yet the numbers of university-generated patents, licensing transactions, and funded research efforts have increased dramatically over recent years. Though companies and universities are always well represented in these matters, investigators themselves typically rely on the institution's legal counsel, or none at all.

What, if anything, can be done about this? One solution that remains unexplored is legal representation for investigators.

The patent laws themselves form the basis for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Philip Goldman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo